Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT00378573 · TERMINATED
Trial details
- NCT number
- NCT00378573
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-09-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.